NAUT Nautilus Biotechnology, Inc.
Healthcare$2.43-4.33%ClosedMarket Cap: $308.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.23
P/S
0.00
EV/EBITDA
-6.00
DCF Value
$-0.15
FCF Yield
-15.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-35.0%
ROA
-32.1%
ROIC
-37.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-16.1M | $-14.7M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-15.4M | $-13.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-66.8M | $-59.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-15.5M | $-13.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-17.1M | $-15.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-18.8M | $-16.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-20.0M | $-17.6M | $— | — |
| FY null | $0.00 | -Infinity% | $-81.5M | $-70.8M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-19.1M | $-16.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-20.8M | $-18.0M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-21.6M | $-18.7M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-20.0M | $-17.0M | $-0.14 | — |